Format

Send to

Choose Destination
Alzheimers Dement. 2017 Jan;13(1):28-37. doi: 10.1016/j.jalz.2016.04.002. Epub 2016 May 10.

Prevalence of dementia subtypes in United States Medicare fee-for-service beneficiaries, 2011-2013.

Author information

1
National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Prevention and Control, Atlanta, GA, USA; Department of Family and Preventive Medicine, Emory University School of Medicine, Atlanta, GA, USA. Electronic address: rgood02@emory.edu.
2
Centers for Medicare & Medicaid Services, Baltimore, MD, USA.
3
Clinical and Translational Neuroscience Unit, Laboratory of Behavioral Neuroscience, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA.
4
Department of Neurology and Human Genetics, Emory University School of Medicine, Atlanta, GA, USA; Division of Neurology, Atlanta VA Medical Center, Atlanta, GA, USA.
5
National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Prevention and Control, Atlanta, GA, USA.

Abstract

INTRODUCTION:

Rapid growth of the older adult population requires greater epidemiologic characterization of dementia. We developed national prevalence estimates of diagnosed dementia and subtypes in the highest risk United States (US) population.

METHODS:

We analyzed Centers for Medicare & Medicaid administrative enrollment and claims data for 100% of Medicare fee-for-service beneficiaries enrolled during 2011-2013 and age ≥68 years as of December 31, 2013 (n = 21.6 million).

RESULTS:

Over 3.1 million (14.4%) beneficiaries had a claim for a service and/or treatment for any dementia subtype. Dementia not otherwise specified was the most common diagnosis (present in 92.9%). The most common subtype was Alzheimer's (43.5%), followed by vascular (14.5%), Lewy body (5.4%), frontotemporal (1.0%), and alcohol induced (0.7%). The prevalence of other types of diagnosed dementia was 0.2%.

DISCUSSION:

This study is the first to document concurrent prevalence of primary dementia subtypes among this US population. The findings can assist in prioritizing dementia research, clinical services, and caregiving resources.

KEYWORDS:

Alzheimer's disease; Dementia; Epidemiology; Medicare; Prevalence; Subtypes

PMID:
27172148
PMCID:
PMC5104686
DOI:
10.1016/j.jalz.2016.04.002
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center